Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer: Observational retrospective study using the WHO pharmacovigilance database

被引：0

作者：

Dolladille, C. ^{[1
]}

Sassier, M. ^{[1
]}

Fedrizzi, S. ^{[1
]}

Chretien, B. ^{[1
]}

Milliez, P. ^{[2
]}

Lelong-Boulouard, V. ^{[1
]}

Alexandre, J. ^{[1
]}

机构：

[1] CHU, Serv Pharmacol, Caen, France

[2] CHU, Serv Cardiol, Caen, France

来源：

关键词：

immune checkpoint inhibitor; cancer; immune-related adverse event; pharmacovigilance database;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PS-056

引用

页码：116 / 116

页数：1